Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Occup Saf Ergon ; 27(1): 8-13, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30354873

RESUMO

Introduction. Both auditory and non-auditory health can be affected by exposure to occupational noise. The aim of this study was to evaluate the association of high occupational noise (at three levels) with systolic blood pressure (SBP), diastolic blood pressure (DBP) and salivary cortisol concentration in an automotive factory. Methods. This study was carried out on 78 male workers from a factory who worked in the warehouse unit (control group: 60-70 dB(A)) and assembly units (two test groups: 75-85 and 85-95 dB(A)). Data were collected through questionnaires and measurement of SBP, DBP, saliva cortisol concentration and body mass index (BMI), prior to and post occupational noise exposure. The measurements were performed twice/day and repeated after 10 days. Results. For each occupational noise level group, there was no significant association between cortisol level with age and BMI. The SBP and DBP in all groups increased significantly. Also, the average cortisol levels were similar in different groups before noise exposure, but were statistically different after occupational noise exposure. Conclusions. High occupational noise exposure increases the cortisol level and blood pressure, which are the major risk factors of cardiovascular disease.


Assuntos
Doenças Cardiovasculares , Hipertensão , Ruído Ocupacional , Exposição Ocupacional , Pressão Sanguínea , Humanos , Hidrocortisona , Masculino , Ruído Ocupacional/efeitos adversos , Exposição Ocupacional/efeitos adversos
2.
Front Neurol ; 10: 378, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31057475

RESUMO

Excessive daytime sleepiness (EDS) is relatively frequent in patients with Parkinson's disease (PD), having a prominent burden on patients' quality of life and causing dangerous events such as motor-vehicle accidents. Previous studies have indicated the role of certain neural tracts in the pathophysiology of sleep disturbances, especially in PD patients. We hypothesized that white matter integrity and connectivity might be altered in patients with PD and EDS. Therefore, this study investigated brain white matter microstructure alterations in patients with Parkinson's disease with EDS (PD-EDS) compared to healthy controls and PD patients without EDS (PD-nEDS). Diffusion MRI connectometry was used to carry out group analysis between PD patients with and without EDS and healthy individuals. EDS in PD patients is associated with decreased connectivity in the left and right fornix, left and right inferior longitudinal fasciculus (ILF), left inferior and middle cerebellar peduncles in comparison to PD-nEDS group. These differences between PD-EDS and PD-nEDS patients reflects microstructural changes with respect to sleep-related circuits, which can pave the way for future investigations considering EDS pathogenesis in Parkinson's disease.

3.
Front Neurol ; 9: 598, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30093877

RESUMO

Parkinson's disease (PD) is a neurodegenerative disorder accompanied by a series of pathological mechanisms which contribute to a variety of motor and non-motor symptoms. Recently, there has been an increasing interest in structural diffusion tensor imaging (DTI) in PD which has shed light on our understanding of structural abnormalities underlying PD symptoms or its associations with pathological mechanisms. One of the white matter tracts shown to be disrupted in PD with a possible contribution to some PD symptoms is the inferior longitudinal fasciculus (ILF). On the whole, lower ILF integrity contributes to thought disorders, impaired visual emotions, cognitive impairments such as semantic fluency deficits, and mood disorders. This review outlines the microstructural changes in ILF associated with systemic inflammation and various PD symptoms like cognitive decline, facial emotion recognition deficit, depression, color discrimination deficit, olfactory dysfunction, and tremor genesis. However, few studies have investigated DTI correlates of each symptom and larger studies with standardized imaging protocols are required to extend these preliminary findings and lead to more promising results.

4.
Artigo em Inglês | MEDLINE | ID: mdl-30450079

RESUMO

Background: Growing evidence shows that impaired signaling of Insulin-like Growth Factor-1 (IGF-1) is associated with neurodegenerative disorders, such as Parkinson's disease (PD). However, there is still controversy regarding its proinflammatory or neuroprotective function. In an attempt to elucidate the contribution of IGF-1 in PD, we aimed to discover the relation between serum IGF-1 levels in drug-naïve early PD patients and cerebrospinal fluid (CSF) biomarkers as well as microstructural changes in brain white matter. Methods: The association between quartiles of serum IGF-1 levels and CSF biomarkers (α-synuclein, dopamine, amyloid-ß1-42, total tau, and phosphorylated tau) was investigated using adjusted regression models in 404 drug-naïve early PD patients with only mild motor manifestations and 188 age- and sex-matched healthy controls (HC) enrolled in the Parkinson's Progression Markers Initiative (PPMI). By using region of interest analysis and connectometry approach, we tracked the white matter microstructural integrity and diffusivity patterns in a subgroup of study participants with available diffusion MRI data to investigate the association between subcomponents of neural pathways with serum IGF-1 levels. Results: PD patients had higher levels of IGF-1 compared to HC, although not statistically significant (mean difference: 3.60, P = 0.44). However, after adjustment for possible confounders and correction for False Discovery Rate (FDR), IGF-1 was negatively correlated with CSF α-synuclein, total and phosphorylated tau levels only in PD subjects. The imaging analysis proved a significant negative correlation (FDR corrected P-value = 0.013) between continuous levels of serum IGF-1 in patients with PD and the connectivity, but not integrity, in following fibers while controlling for age, sex, body mass index, depressive symptoms, education years, cognitive status and disease duration: middle cerebellar peduncle, cingulum, genu and splenium of the corpus callosum. No significant association was found between brain white matter microstructral measures or CSF markers of healthy controls and levels of IGF-1. Conclusion: Altered connectivity in specific white matter structures, mainly involved in cognitive and motor deterioration, in association with higher serum IGF-1 levels might propose IGF-1 as a potential associate of worse outcome in response to higher burden of α-synucleinopathy and tauopathy in PD.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA